MedPath

Safety and Efficacy of a New Enhanced Monofocal Intraocular Lens

Phase 3
Conditions
Health Condition 1: O- Medical and SurgicalHealth Condition 2: H259- Unspecified age-related cataract
Registration Number
CTRI/2024/05/067844
Lead Sponsor
ethradhama Super Speciality Eye Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Eyes with senile cataract of grades 1-4 Nuclear Sclerosis, Cortical cataracts, Posterior subcapsular cataract

Corneal astigmatism equal to or less than 1D

IOL power between +10D to +30D

In the bag IOL implantation

Exclusion Criteria

Eyes with corneal astigmatism more than 1.0 D

Hypermature/morgagnian/intumescent and brunescent cataracts more than NS 4

Corneal disorders like- irregular astigmatism, keratoconus, pellucid marginal degeneration, corneal dystrophy, low endothelial cell counts less than 1500

Pupillary abnormalities

History of glaucoma or intraocular inflammation

Macular disease or retinopathy, neuro-ophthalmic diseases, active infections, previous ocular surgery of any kind, any other ocular pathology.

Intraoperative or postoperative complications

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath